{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:46:36Z","timestamp":1769600796681,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ejso.2020.07.037","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T21:51:17Z","timestamp":1596577877000},"page":"486-489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Systemic exposure of oxaliplatin and docetaxel in gastric cancer patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy"],"prefix":"10.1016","volume":"47","author":[{"given":"W.J.","family":"Koemans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5119-4154","authenticated-orcid":false,"given":"R.T.","family":"van der Kaaij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.C.E.","family":"Wassenaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1896-5105","authenticated-orcid":false,"given":"C.","family":"Grootscholten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Boot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Boerma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Los","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Imhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.H.M.","family":"Schellens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Rosing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.D.R.","family":"Huitema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.W.","family":"van Sandick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2020.07.037_bib1","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ijc.28373","article-title":"Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors","volume":"134","author":"Thomassen","year":"2014","journal-title":"Int J Canc"},{"key":"10.1016\/j.ejso.2020.07.037_bib2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/0284186X.2013.850740","article-title":"Chemotherapy as palliative treatment for peritoneal carcinomatosis of gastric origin","volume":"53","author":"Thomassen","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejso.2020.07.037_bib3","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ejso.2016.04.053","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: results from a Chinese center","volume":"42","author":"Wu","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.07.037_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejso.2013.10.019","article-title":"Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials","volume":"40","author":"Coccolini","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.07.037_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10120-019-00978-0","article-title":"Peritoneal metastasis in gastric cancer: results from the German database","volume":"23","author":"Rau","year":"2020","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejso.2020.07.037_bib6","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1245\/s10434-019-07450-4","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer with peritoneal carcinomatosis: multicenter study of Spanish group of peritoneal oncologic surgery (GECOP)","volume":"26","author":"Manzanedo","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.07.037_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1471-2407-14-183","article-title":"GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study","volume":"14","author":"Glehen","year":"2014","journal-title":"BMC Canc"},{"key":"10.1016\/j.ejso.2020.07.037_bib8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12885-019-5640-2","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)","volume":"19","author":"Koemans","year":"2019","journal-title":"BMC Canc"},{"key":"10.1016\/j.ejso.2020.07.037_bib9","first-page":"3380","article-title":"Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy","volume":"49","author":"Los","year":"1989","journal-title":"Canc Res"},{"key":"10.1016\/j.ejso.2020.07.037_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-4613-1247-5_4","article-title":"Peritoneal-plasma barrier","volume":"82","author":"Jacquet","year":"1996","journal-title":"Canc Treat Res"},{"key":"10.1016\/j.ejso.2020.07.037_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/SLA.0b013e3182193143","article-title":"Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis: a study of the effect of heat on intraperitoneal oxaliplatin using a murine model","volume":"254","author":"Piche","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2020.07.037_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/026567399285765","article-title":"Invited Review: for the clinical application of thermochemotherapy given at mild temperatures","volume":"15","author":"Urano","year":"1999","journal-title":"Int J Hyperther"},{"key":"10.1016\/j.ejso.2020.07.037_bib13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.critrevonc.2015.04.004","article-title":"Selection of chemotherapy for hyperthermic intraperitoneal use in gastric cancer","volume":"95","author":"Braam","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejso.2020.07.037_bib14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2196\/resprot.7790","article-title":"Treatment of peritoneal dissemination in stomach cancer patients with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): rationale and design of the PERISCOPE study","volume":"6","author":"van der Kaaij","year":"2017","journal-title":"JMIR Res Protoc"},{"key":"10.1016\/j.ejso.2020.07.037_bib15","article-title":"Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results","author":"van der Kaaij","year":"2020","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2020.07.037_bib16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00280-007-0654-x","article-title":"Pharmacokinetics of heated intraperitoneal oxaliplatin","volume":"62","author":"Ferron","year":"2008","journal-title":"Canc Chemother Pharmacol"},{"key":"10.1016\/j.ejso.2020.07.037_bib17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ejso.2006.03.004","article-title":"Heated intra-operative intraperitoneal oxaliplatin alone and in combination with intraperitoneal irinotecan: pharmacologic studies","volume":"32","author":"Elias","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.07.037_bib18","first-page":"2496","article-title":"Pharmacokinetics of docetaxel during hyperthermic intraperitoneal chemotherapy for peritoneal metastasis","volume":"41","author":"Yonemura","year":"2014","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.ejso.2020.07.037_bib19","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ejso.2006.03.008","article-title":"Intraperitoneal chemotherapy with taxanes for ovarian cancer with peritoneal dissemination","volume":"32","author":"de Bree","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.07.037_bib20","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/jms.1087","article-title":"Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate","volume":"41","author":"Brouwers","year":"2006","journal-title":"J\u00a0Mass Spectrom"},{"key":"10.1016\/j.ejso.2020.07.037_bib21","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1016\/j.jchromb.2011.08.034","article-title":"A\u00a0sensitive combined assay for the quantification of paclitaxel, docetaxel and ritonavir in human plasma using liquid chromatography coupled with tandem mass spectrometry","volume":"879","author":"Hendrikx","year":"2011","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.ejso.2020.07.037_bib22","first-page":"1205","article-title":"Clinical pharmacokinetics of oxaliplatin: a critical review","volume":"6","author":"Graham","year":"2000","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.ejso.2020.07.037_bib23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000066229","article-title":"Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions after complete resection of peritoneal carcinomatosis","volume":"63","author":"Elias","year":"2002","journal-title":"Oncology"},{"key":"10.1016\/j.ejso.2020.07.037_bib24","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1200\/JCO.2005.03.082","article-title":"Prospective evaluation of the pharmacokinetics and toxicity profile of docetaxel in the elderly","volume":"23","author":"ten Tije","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.07.037_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s40262-013-0102-5","article-title":"The effect of St John\u2019s wort on the pharmacokinetics of docetaxel","volume":"53","author":"Goey","year":"2014","journal-title":"Clin Pharmacokinet"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320306648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320306648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:36:07Z","timestamp":1760060167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798320306648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0748798320306648"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.07.037","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic exposure of oxaliplatin and docetaxel in gastric cancer patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.07.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}